A new trial investigating the use of stereotactic body radiotherapy (SBRT) for unresected breast cancer has begun at the Sunybrook Regional Cancer Centre in Toronto. The trial will involve 24 patients with advanced breast cancer, who either do not qualify as candidates for surgery or who have declined surgery as a treatment option. These patients will each receive "4 fractions of radiation therapy over 12-15 days as the primary treatment modality.
To read more about this trial, click here.
No comments:
Post a Comment